Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.516, 2006-01, pp. : 1-1
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
First-line sunitinib cost-effective alternative to interferon-α in renal cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 561, 2008-01 ,pp. :
Access to resources
Recommend
Sunitinib cost-effective alternative to interferon-α in renal cancer
Inpharma, Vol. 1, Iss. 1654, 2008-01 ,pp. :
Sunitinib cost effective for renal cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 532, 2007-01 ,pp. :
Alteplase cost-effective option for acute ischaemic stroke
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 333, 2001-01 ,pp. :
CRT a cost-effective option in Scandinavian settings
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 568, 2008-01 ,pp. :